Home › Adaptive Biotechnologies Receives $2.53 million Phase II Sbir to...
 

Keywords :   


Adaptive Biotechnologies Receives $2.53 million Phase II Sbir to...

2013-09-14 06:04:40| Logistics - Topix.net

Adaptive Biotechnologies announced today that it received a $2.53 million Phase II Small Business Innovation Research award from the National Heart, Lung, and Blood Institute, a division of the NIH, to commercialize a test to measure the ability of a cancer patient's adaptive immune system to fight infection after a cord blood transplant.

Tags: to million phase receives

Category:Transportation and Logistics

Latest from this category

All news
04.11Tropical Depression Eighteen Graphics
04.11Tropical Depression Eighteen Public Advisory Number 4A
04.11Remnants of Patty Graphics
04.11Atlantic Tropical Weather Outlook
04.11Eastern North Pacific Tropical Weather Outlook
04.11Tropical Depression Eighteen Graphics
04.11Remnants of Patty Graphics
04.11Remnants of Patty Forecast Discussion Number 10
Transportation and Logistics »
04.11Tropical Depression Eighteen Graphics
04.11Tropical Depression Eighteen Public Advisory Number 4A
04.11Remnants of Patty Graphics
04.11Atlantic Tropical Weather Outlook
04.11Eastern North Pacific Tropical Weather Outlook
04.11Paper Excellence Group Rebrands as Domtar
04.11Registration Open for 2025 Waterborne Symposium
04.11ROSS Ribbon Blenders Provide Safe, Efficient Bulk Blending
More »